Related Experiment Video

Updated: Jul 4, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor

P P Scaglioni1, T M Yung, S Choi

  • 1Division of Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390-8852, USA. pier.scaglioni@utsouthwestern.edu

Molecular and Cellular Biochemistry
|June 21, 2008
PubMed

Insights

The PML tumor suppressor

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The PML tumor suppressor is crucial for controlling cell growth, apoptosis, and senescence, and its loss is common in various cancers.
  • Casein kinase 2 (CK2) is an oncogenic protein kinase often overexpressed in tumors, linked to poor prognosis in non-small cell lung cancer.

Purpose of the Study:

  • To investigate the mechanism controlling PML protein levels in cancer cells.
  • To explore the role of CK2 in PML degradation and its implications for tumor suppression.
  • To evaluate the therapeutic potential of CK2 inhibition in cancer treatment.

Main Methods:

  • Studied PML degradation in immortalized and tumor-derived cell lines using ubiquitin/proteasome pathways.
  • Investigated the direct phosphorylation of PML at Ser517 by CK2.
  • Utilized PML mutants resistant to CK2 phosphorylation.
  • Assessed tumor suppressive functions including apoptosis, senescence, and xenograft models.
  • Examined the effects of pharmacological CK2 inhibition.

Main Results:

  • PML undergoes ubiquitin/proteasome-mediated degradation, dependent on CK2 phosphorylation at PML Ser517.
  • PML mutants resistant to CK2 phosphorylation exhibit enhanced tumor suppressive functions.
  • Pharmacological inhibition of CK2 significantly enhances PML's tumor suppressive properties.

Conclusions:

  • CK2-mediated phosphorylation is a key post-translational mechanism regulating PML protein levels in cancer.
  • Targeting CK2 activity could restore PML's tumor suppressor functions.
  • CK2 inhibitors represent a potential therapeutic strategy for cancer treatment.

More Related Videos

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...